瑞众保险笪莹、王聪：新《公司法》背景下保险公司董事履职评价机制研究 ｜保险家论道专栏

Core Viewpoint - The article discusses the evolution and optimization of the board performance evaluation system for insurance companies in China, emphasizing the need for alignment with the new Company Law and the importance of enhancing governance and accountability in the insurance sector [4][28]. Summary by Sections Development History of Board Performance Evaluation - The evolution of the board performance evaluation system reflects the modernization of corporate governance in financial institutions, transitioning from principle-based norms to a systematic mechanism tailored to the insurance industry's characteristics [5]. Exploration and Initial Stage (Before 2010) - The initial framework for board duties was established, with the 2005 Company Law defining the fiduciary and diligence obligations of directors, although specific evaluation standards were not detailed [6]. - The 2009 Insurance Law reinforced director accountability, establishing legal support for performance evaluation [6]. - Regulatory guidance began to emerge, with the 2006 guidelines requiring annual reporting of directors' performance to shareholders [6][7]. System Formation Stage (2010-2023) - This period saw the establishment of comprehensive regulatory requirements for board performance evaluation, with key milestones in 2010 and 2021 [8]. - The 2010 notification introduced evaluation indicators for directors, marking a significant step in formalizing the evaluation process [8]. - The 2021 implementation of the evaluation method expanded the scope to include insurance institutions, creating a systematic evaluation framework with specific criteria for performance assessment [9]. Deepening Transformation Stage (2024-Present) - The new Company Law, effective in 2024, introduces enhanced fiduciary duties and a "reasonable care" standard for directors, necessitating a shift in evaluation mechanisms to align with these legal requirements [10]. - The evaluation process must evolve to balance accountability and support for directors, focusing on professional, precise, and efficient performance assessments [11]. Challenges in Current Evaluation Mechanism - The current evaluation system often prioritizes regulatory compliance over substantive performance, leading to a lack of clarity in responsibility and accountability [12]. - There is insufficient differentiation in evaluation criteria for various types of directors, which may not accurately reflect their distinct roles and contributions [13]. - The evaluation process is often formalistic, lacking standardized procedures and clear operational guidelines, which can lead to subjective biases [14]. Recommendations for Optimization - The article suggests several pathways for enhancing the evaluation mechanism, including: - Clarifying the responsibility of evaluation bodies based on company type and structure [18]. - Developing a multi-dimensional evaluation indicator system that incorporates strategic, risk, performance, and compliance aspects [18]. - Balancing short-term performance metrics with long-term strategic goals to ensure sustainable governance [20]. - Introducing incentives for proactive contributions beyond basic compliance, fostering an entrepreneurial spirit among directors [22]. - Establishing a connection between evaluation results and liability insurance to mitigate risks associated with compliance [25]. Conclusion - A scientifically sound board performance evaluation mechanism is essential for implementing the new Company Law and enhancing corporate governance in the insurance sector, ultimately supporting the industry's long-term stability and growth [28].